Recent Quotes (30 days)

You have no recent quotes
chg | %

Promis Neurosciences Inc  

(Public, TSE:PMN)   Watch this stock  
Find more results for TSE:AMF
0.140
+0.005 (3.70%)
Dec 2 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.14 - 0.14
52 week 0.04 - 0.24
Open 0.14
Vol / Avg. 343,400.00/103,601.00
Mkt cap 24.53M
P/E     -
Div/yield     -
EPS -0.02
Shares 181.71M
Beta -1.61
Inst. own     -
Nov 2, 2016
Q3 2016 Promis Neurosciences Inc Earnings Release
Sep 13, 2016
Promis Neurosciences Inc at Rodman & Renshaw Global Investment Conference
  

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin - -10636.66%
Operating margin - -10516.40%
EBITD margin - -10124.02%
Return on average assets -259.34% -293.50%
Return on average equity -467.51% -1055.86%
CDP Score - -

Address

Suite 200, 1920 Yonge Street
TORONTO, ON M4S 3E2
Canada
+1-416-8476898 (Phone)
+1-416-8476899 (Fax)

Website links

Description

ProMIS Neurosciences Inc., formerly Amorfix Life Sciences Ltd., is a Canada-based development-stage biotech company. The Company discovers and develops precision therapeutics with companion diagnostics for early detection and treatment of neurodegenerative diseases, in particular Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS). The assays are developed using its technologies, Epitope Protection and AMFIA. It is developing therapies targeting misfolded, neurotoxic forms of Amyloid beta in AD and superoxide dismutase 1 (SOD1) in ALS. The Company focuses to use its platform to discover further targets for precision medicine solutions through identification of target epitopes on other misfolded strains of Amyloid beta. The Company focuses to evaluate targets on misfolded strains of tau, another protein implicated in neurodegenerative diseases, including Alzheimer's. The Company has not generated any product revenues.

Officers and directors

Eugene Williams Executive Chairman of the Board
Elliot Goldstein M.D. President, Chief Executive Officer, Director
Age: 65
Neil Cashman M.D. Co-Founder, Chief Scientific Officer, Director
Janet Clennett Director - Finance, Acting Chief Financial Officer
Steven S. Plotkin Ph.D. Chief Physics Officer
Robert Gundel Ph.D. Director
Richard J. Gregory Ph.D. Director
Age: 58
Johannes M. Roth Independent Director
Age: 36